Cooper Companies | COO - Despesas De Vendas E Administração

Preço das Ações
69.96
Mudança Diária
-0.75 -1.06%
Mensal
-15.65%
Anual
-14.38%
Q1 Previsão
67.86




Despesas De Vendas E Administração Alterar Data
Abbott USD 3.13B 125M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Bausch Health Companies USD 801M 6M 2025-12
Baxter International USD 761M 53M 2025-12
Bayer EUR 4.05B 647M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dentsply International USD 383M 28M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Hologic USD 2.5B 2.24B 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
J&J USD 6.75B 831M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Novartis USD 3.44B 132M 2025-12
ResMed USD 278.4M 19.2M 2025-12
STAAR Surgical USD 38.94M 20.44M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Utah Medical Products USD 1.87M 50K 2024-09
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12